BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36141235)

  • 1. Tackling Thyroid Cancer in Europe-The Challenges and Opportunities.
    Horgan D; Führer-Sakel D; Soares P; Alvarez CV; Fugazzola L; Netea-Maier RT; Jarzab B; Kozaric M; Bartes B; Schuster-Bruce J; Dal Maso L; Schlumberger M; Pacini F
    Healthcare (Basel); 2022 Aug; 10(9):. PubMed ID: 36141235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe.
    Horgan D; Curigliano G; Rieß O; Hofman P; Büttner R; Conte P; Cufer T; Gallagher WM; Georges N; Kerr K; Penault-Llorca F; Mastris K; Pinto C; Van Meerbeeck J; Munzone E; Thomas M; Ujupan S; Vainer GW; Velthaus JL; André F
    J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tackling Mantle Cell Lymphoma in Europe.
    Horgan D; Walewski J; Aurer I; Visco C; Giné E; Fetica B; Jerkeman M; Kozaric M; da Silva MG; Dreyling M
    Healthcare (Basel); 2022 Sep; 10(9):. PubMed ID: 36141294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?
    Horgan D; Baird AM; Middleton M; Mihaylova Z; Van Meerbeeck JP; Vogel-Claussen J; Van Schil PE; Malvehy J; Ascierto PA; Dube F; Zaiac M; Lal JA; Kamińska-Winciorek G; Donia M; André T; Kozaric M; Osterlund P; Dumitrascu DL; Bertolaccini L
    Healthcare (Basel); 2022 Aug; 10(9):. PubMed ID: 36141230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring.
    Horgan D; Čufer T; Gatto F; Lugowska I; Verbanac D; Carvalho Â; Lal JA; Kozaric M; Toomey S; Ivanov HY; Longshore J; Malapelle U; Hasenleithner S; Hofman P; Alix-Panabières C
    Healthcare (Basel); 2022 Sep; 10(9):. PubMed ID: 36141326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tackling rare diseases at European level: why do we need a harmonized framework?
    Taruscio D; Trama A; Stefanov R
    Folia Med (Plovdiv); 2007; 49(1-2):59-67. PubMed ID: 18018471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Framework for Adoption of Next-Generation Sequencing (NGS) Globally in the Oncology Area.
    Horgan D; Hamdi Y; Lal JA; Nyawira T; Meyer S; Kondji D; Francisco NM; De Guzman R; Paul A; Bernard B; Reddy Nallamalla K; Park WY; Triapthi V; Tripathi R; Johns A; Singh MP; Phipps ME; Dube F; Rasheed HMA; Kozaric M; Pinto JA; Doral Stefani S; Aponte Rueda ME; Fujita Alarcon R; Barrera-Saldana HA
    Healthcare (Basel); 2023 Feb; 11(3):. PubMed ID: 36767006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propelling Health Care into the Twenties.
    Horgan D; Borisch B; Richer E; Bernini C; Kalra D; Lawler M; Ciliberto G; Van Poppel H; Paradiso A; Riegman P; Triberti S; Metspalu A; Chiti A; Macintyre E; Boccia S; Calvo F; Schatz D; Koeva-Balabanova J; Jonsson B
    Biomed Hub; 2020; 5(2):15-67. PubMed ID: 32775335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tackling the translational challenges of multi-omics research in the realm of European personalised medicine: A workshop report.
    Oldoni E; Saunders G; Bietrix F; Garcia Bermejo ML; Niehues A; 't Hoen PAC; Nordlund J; Hajduch M; Scherer A; Kivinen K; Pitkänen E; Mäkela TP; Gut I; Scollen S; Kozera Ł; Esteller M; Shi L; Ussi A; Andreu AL; van Gool AJ
    Front Mol Biosci; 2022; 9():974799. PubMed ID: 36310597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting Cancer around the World: A Framework for Action.
    Horgan D; Mia R; Erhabor T; Hamdi Y; Dandara C; Lal JA; Domgue JF; Ewumi O; Nyawira T; Meyer S; Kondji D; Francisco NM; Ikeda S; Chuah C; De Guzman R; Paul A; Reddy Nallamalla K; Park WY; Tripathi V; Tripathi R; Johns A; Singh MP; Phipps ME; Dube F; Whittaker K; Mukherji D; Rasheed HMA; Kozaric M; Pinto JA; Doral Stefani S; Augustovski F; Aponte Rueda ME; Fujita Alarcon R; Barrera-Saldana HA
    Healthcare (Basel); 2022 Oct; 10(11):. PubMed ID: 36360466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Europe combating cancer: the European Union's commitment to cancer research in the 6th Framework Programme.
    Jungbluth S; Kelm O; van de Loo JW; Manoussaki E; Vidal M; Hallen M; Trias OQ
    Mol Oncol; 2007 Jun; 1(1):14-8. PubMed ID: 19383283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in Europe.
    de la Fouchardière C; Fugazzola L; Locati LD; Alvarez CV; Peeters RP; Camacho P; Simon IM; Jarząb B; Netea-Maier R
    Endocrine; 2024 Mar; 83(3):585-593. PubMed ID: 38001324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthy bi-regional connection: The EU-LAC Health initiative has promoted equitable and collaborative health research and innovation.
    Corral T; de Román M; Gómez-Núñez AJ; Mourenza B; Quental C; Splett-Rudolf S; de Andrés R
    Health Res Policy Syst; 2018 Nov; 16(1):114. PubMed ID: 30470236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How can a joint European health technology assessment provide an 'additional benefit' over the current standard of national assessments? : Insights generated from a multi-stakeholder survey in hematology/oncology.
    Julian E; Gianfrate F; Sola-Morales O; Mol P; Bergmann JF; Salmonson T; Hebborn A; Grande M; Ruof J
    Health Econ Rev; 2022 Jun; 12(1):30. PubMed ID: 35652987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The European Cancer Patient Coalition and its central role in connecting stakeholders to advance patient-centric solutions in the mission on cancer.
    de Lorenzo F; Apostolidis K
    Mol Oncol; 2019 Mar; 13(3):653-666. PubMed ID: 30657631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries.
    Pisana A; Wettermark B; Kurdi A; Tubic B; Pontes C; Zara C; Van Ganse E; Petrova G; Mardare I; Fürst J; Roig-Izquierdo M; Melien O; Bonanno PV; Banzi R; Marković-Peković V; Mitkova Z; Godman B
    Front Pharmacol; 2022; 13():873556. PubMed ID: 35865969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.